类风湿关节炎患者接受肿瘤坏死因子-α抑制剂治疗后出现二期梅毒。 - Suppr | 超能文献

Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.

作者信息

Asahina Akihiko, Ishii Norihisa, Tohma Shigeto

出版信息

J Dermatol. 2012 Feb;39(2):199-201. doi: 10.1111/j.1346-8138.2011.01243.x. Epub 2011 Apr 5.

DOI:10.1111/j.1346-8138.2011.01243.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.类风湿关节炎患者接受肿瘤坏死因子-α抑制剂治疗后出现二期梅毒。

J Dermatol. 2012 Feb;39(2):199-201. doi: 10.1111/j.1346-8138.2011.01243.x. Epub 2011 Apr 5.

2

[TNF targetting therapy for rheumatoid arthritis].[类风湿关节炎的肿瘤坏死因子靶向治疗]

Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1787-94. doi: 10.2169/naika.95.1787.

3

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.抗肿瘤坏死因子-α生物制剂治疗类风湿关节炎无不良影响：5 年随访。

Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13.

4

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.TNF-α 拮抗剂在类风湿关节炎中的生存情况：一项长期研究。

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):31-8. Epub 2012 Mar 6.

5

Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis.一名类风湿关节炎患者出现与依那西普和阿达木单抗相关的复发性肝毒性，但与英夫利昔单抗无关。

Rev Esp Enferm Dig. 2012 May;104(5):282-4. doi: 10.4321/s1130-01082012000500014.

6

[Should we be afraid of the anti-TNFalpha drugs in 2008?].2008年我们应该害怕抗肿瘤坏死因子α药物吗？

Rev Med Interne. 2008 Dec;29(12):971-4. doi: 10.1016/j.revmed.2008.04.022. Epub 2008 Jun 20.

7

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study.对停用先前抗肿瘤坏死因子治疗的活动性类风湿关节炎患者使用戈利木单抗联合甲氨蝶呤疗效的深入分析：GO-AFTER研究的事后分析

Ann Rheum Dis. 2014 Oct;73(10):1811-8. doi: 10.1136/annrheumdis-2013-203435. Epub 2013 Jul 29.

8

Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.肿瘤坏死因子α抑制剂与甲氨蝶呤或来氟米特联合使用的比较疗效

Ann Rheum Dis. 2009 Dec;68(12):1856-62. doi: 10.1136/ard.2008.098467. Epub 2009 Jan 6.

9

Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.接受抗TNF-α药物治疗的类风湿关节炎患者发生带状疱疹的风险。

JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146.

10

Which TNF inhibitor for rheumatoid arthritis?哪种肿瘤坏死因子抑制剂用于治疗类风湿性关节炎？

Med Lett Drugs Ther. 2010 May 17;52(1338):38-9.

引用本文的文献

1

Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye.聚焦阿达木单抗：在土耳其一家三级转诊中心评估其在非感染性葡萄膜炎中的有效性和安全性

Turk J Ophthalmol. 2025 Aug 21;55(4):207-214. doi: 10.4274/tjo.galenos.2025.67513.

2

Cutaneous Eruption in a Crohn's Disease Patient Under Tumor Necrosis Alpha Inhibitor Treatment: A Rare Case of Syphilis.一名接受肿瘤坏死因子α抑制剂治疗的克罗恩病患者出现皮肤疹：一例罕见的梅毒病例

Cureus. 2024 Mar 26;16(3):e57003. doi: 10.7759/cureus.57003. eCollection 2024 Mar.

3

Musculoskeletal manifestations of syphilis in adults: secondary syphilis presenting with ankle inflammatory arthritis and bone involvement with calvarial and sternal lesions. What the rheumatologist needs to know.成人梅毒的肌肉骨骼表现：二期梅毒表现为踝关节炎症性关节炎和伴有颅骨和胸骨病变的骨骼受累。风湿病医生需要了解的知识。

Clin Rheumatol. 2023 Apr;42(4):1195-1203. doi: 10.1007/s10067-022-06458-8. Epub 2022 Dec 1.